364 related articles for article (PubMed ID: 22359450)
1. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.
Saxena V; Hussain MD
Int J Nanomedicine; 2012; 7():713-21. PubMed ID: 22359450
[TBL] [Abstract][Full Text] [Related]
2. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
Saxena V; Hussain MD
J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs.
Butt AM; Mohd Amin MC; Katas H
Int J Nanomedicine; 2015; 10():1321-34. PubMed ID: 25709451
[TBL] [Abstract][Full Text] [Related]
4. Gambogic acid-loaded pH-sensitive mixed micelles for overcoming breast cancer resistance.
Wang S; Yang Y; Wang Y; Chen M
Int J Pharm; 2015 Nov; 495(2):840-8. PubMed ID: 26407923
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
6. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.
Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L
Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426
[TBL] [Abstract][Full Text] [Related]
7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin.
Gao Y; Li LB; Zhai G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):194-9. PubMed ID: 18325744
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
[TBL] [Abstract][Full Text] [Related]
10. mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer.
Wang S; Chen R; Morott J; Repka MA; Wang Y; Chen M
Expert Opin Drug Deliv; 2015 Mar; 12(3):361-73. PubMed ID: 25392124
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
12. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid.
Shen C; Zhu J; Song J; Wang J; Shen B; Yuan H; Li X
Drug Dev Ind Pharm; 2020 Jul; 46(7):1100-1107. PubMed ID: 32463722
[No Abstract] [Full Text] [Related]
13. Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization.
Chary PS; Bansode A; Rajana N; Bhavana V; Singothu S; Sharma A; Guru SK; Bhandari V; Mehra NK
Int J Pharm; 2024 May; 657():124109. PubMed ID: 38626846
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
[TBL] [Abstract][Full Text] [Related]
15. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein.
Jin Y; Zhang Z; Zhao T; Liu X; Jian L
J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136
[TBL] [Abstract][Full Text] [Related]
16. Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles.
Hao J; Tong T; Jin K; Zhuang Q; Han T; Bi Y; Wang J; Wang X
Int J Nanomedicine; 2017; 12():2279-2292. PubMed ID: 28392687
[TBL] [Abstract][Full Text] [Related]
17. TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer.
Song J; Huang H; Xia Z; Wei Y; Yao N; Zhang L; Yan H; Jia X; Zhang Z
Integr Cancer Ther; 2016 Sep; 15(3):390-9. PubMed ID: 26293804
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers.
Patra A; Satpathy S; Shenoy AK; Bush JA; Kazi M; Hussain MD
Int J Nanomedicine; 2018; 13():2869-2881. PubMed ID: 29844670
[TBL] [Abstract][Full Text] [Related]
19. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
[TBL] [Abstract][Full Text] [Related]
20. A novel mixed polymeric micelle for co-delivery of paclitaxel and retinoic acid and overcoming multidrug resistance: synthesis, characterization, cytotoxicity, and pharmacokinetic evaluation.
Emami J; Rezazadeh M; Mashayekhi M; Rostami M; Jahanian-Najafabadi A
Drug Dev Ind Pharm; 2018 May; 44(5):729-740. PubMed ID: 29235901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
